# Everolimus in Treating Patients With Recurrent Low-Grade Glioma

> **NCT00823459** · PHASE2 · COMPLETED · sponsor: **Susan Chang** · enrollment: 58 (actual)

## Conditions studied

- Adult Diffuse Astrocytoma
- Adult Mixed Glioma
- Adult Oligodendroglioma
- Adult Subependymal Giant Cell Astrocytoma
- Recurrent Adult Brain Neoplasm

## Interventions

- **DRUG:** Everolimus
- **OTHER:** Archival Tissue Analysis

## Key facts

- **NCT ID:** NCT00823459
- **Lead sponsor:** Susan Chang
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01-23
- **Primary completion:** 2017-06-12
- **Final completion:** 2017-11-13
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00823459

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00823459, "Everolimus in Treating Patients With Recurrent Low-Grade Glioma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00823459. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*